Home › Companies › LINEAGE CELL THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and LINEAGE CELL THERAPEUTICS INC.’s Form 8-K, filed July 2, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 26, 2025: 10 items on LINEAGE CELL THERAPEUTICS INC.’s Form 8-K, filed July 2, 2025: 7 elected · 3 approved.
Meeting of January 27, 2025: 1 item on LINEAGE CELL THERAPEUTICS INC.’s Form 8-K, filed January 27, 2025: 1 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore LINEAGE CELL THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are LINEAGE CELL THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 2, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. LINEAGE CELL THERAPEUTICS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael H. Mulroy | 99,312,637 | -- | -- | 1,174,790 | 59,813,557 | 99% | Elected | — |
| Elect Director: Dipti Amin | 99,362,438 | -- | -- | 1,124,989 | 59,813,557 | 99% | Elected | — |
| Elect Director: Deborah Andrews | 98,593,393 | -- | -- | 1,894,034 | 59,813,557 | 98% | Elected | — |
| Elect Director: Angus C. Russell | 99,373,222 | -- | -- | 1,114,205 | 59,813,557 | 99% | Elected | — |
| Elect Director: Neal C. Bradsher | 98,861,237 | -- | -- | 1,626,190 | 59,813,557 | 98% | Elected | — |
| Elect Director: Brian M. Culley | 98,593,167 | -- | -- | 1,894,260 | 59,813,557 | 98% | Elected | — |
| Elect Director: Anula Jayasuriya | 99,077,018 | -- | -- | 1,410,409 | 59,813,557 | 99% | Elected | — |
| 2. The appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 by the following votes | 158,952,692 | 912,282 | 436,010 | -- | -- | 99.4% | Approved | — |
| 3. The compensation paid to the Company's named executive officers, as set forth in the Proxy Statement, by the following votes | 96,071,162 | 3,804,451 | 611,814 | -- | 59,813,557 | 96% | Approved | — |
| 4. The EIP Amendment by the votes set forth below | 88,575,737 | 11,560,925 | 350,765 | -- | 59,813,557 | 88% | Approved | — |
Source: LINEAGE CELL THERAPEUTICS INC., Form 8-K, filed with the SEC on July 2, 2025 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 2. The adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of proposal 1 if there were not sufficient votes to approve such proposal at the time of the meeting or any adjournment or postponement thereof | 112,392,014 | 8,458,712 | 375,748 | -- | 0 | 93% | Approved | — |
Source: LINEAGE CELL THERAPEUTICS INC., Form 8-K, filed with the SEC on January 27, 2025 — read the filing on EDGAR.
Each item below shows how the 120 asset managers that disclosed a LINEAGE CELL THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LINEAGE CELL THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Angus C. Russell
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Angus C. Russell”): 99,373,222 for, 1,114,205 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,246,255 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Anula Jayasuriya
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Anula Jayasuriya”): 99,077,018 for, 1,410,409 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,246,255 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Brian M. Culley
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Brian M. Culley”): 98,593,167 for, 1,894,260 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,246,255 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Deborah Andrews
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Deborah Andrews”): 98,593,393 for, 1,894,034 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,246,255 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Dipti Amin
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dipti Amin”): 99,362,438 for, 1,124,989 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,246,255 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael H. Mulroy
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael H. Mulroy”): 99,312,637 for, 1,174,790 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,235,599 for, 10,656 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 10,656 | Withhold |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Neal C. Bradsher
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“Elect Director: Neal C. Bradsher”): 98,861,237 for, 1,626,190 withheld, per its Form 8-K filed July 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Shareholders elected the seven nominees named below to the Board to hold office until the Company's 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,235,599 for, 10,656 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 10,656 | Withhold |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held January 27, 2025.
100% of fund votes cast · no official result
Description as filed by funds: To approve, for purposes of complying with NYSE American LLC listing standards and requirements, the issuance of the Company's common shares and common warrants pursuant to the terms of the securities purchase agreement, dated November 19, 2024, between the Company and Broadwood Partners, L.P., the Company's common shares issuable upon exercise of such common warrants.
The 21 asset managers below reported 10,752,505 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,286,793 | 0 | 0 | 0 | For |
| Fidelity | 1,408,438 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 360,685 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Equitable | 119,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 66,979 | 0 | 0 | 0 | For |
| Pacific Life | 66,327 | 0 | 0 | 0 | For |
| TIAA | 62,808 | 0 | 0 | 0 | For |
| State Street | 47,331 | 0 | 0 | 0 | For |
| ProShares | 42,841 | 0 | 0 | 0 | For |
| Northern Trust | 39,931 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,518 | 0 | 0 | 0 | For |
| DWS | 19,932 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| Victory Capital | 7,443 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,062 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
| Guggenheim | 2,091 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Meeting held January 27, 2025.
100% of fund votes cast · no official result
Description as filed by funds: TO APPROVE, FOR PURPOSES OF COMPLYING WITH NYSE AMERICAN LLC LISTING STANDARDS AND REQUIREMENTS, THE ISSUANCE OF THE COMPANY'S COMMON SHARES AND COMMON WARRANTS PURSUANT TO THE TERMS OF THE SECURITIES PURCHASE AGREEMENT, DATED NOVEMBER 19, 2024, BETWEEN THE COMPANY AND BROADWOOD PARTNERS, L.P., AND THE COMPANY'S COMMON SHARES ISSUABLE UPON EXERCISE OF SUCH COMMON WARRANTS.
The 8 asset managers below reported 3,398,353 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,786,683 | 0 | 0 | 0 | For |
| Charles Schwab | 416,223 | 0 | 0 | 0 | For |
| Global X | 81,445 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,600 | 0 | 0 | 0 | For |
| John Hancock | 32,559 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 31,143 | 0 | 0 | 0 | For |
| Jackson National | 4,400 | 0 | 0 | 0 | For |
| apricus wealth, LLC | 1,300 | 0 | 0 | 0 | For |
Meeting held January 27, 2025.
93% Approved · of votes cast
Description as filed by funds: TO APPROVE THE ADJOURNMENT OF THE MEETING, IF NECESSARY OR ADVISABLE, TO SOLICIT ADDITIONAL PROXIES IN FAVOR OF THE FOREGOING PROPOSAL IF THERE ARE NOT SUFFICIENT VOTES TO APPROVE SUCH PROPOSAL AT THE TIME OF THE MEETING OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF.
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“2. The adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of proposal 1 if there were not sufficient votes to approve such proposal at the time of the meeting or any adjournment”): 112,392,014 for, 8,458,712 against — passed, per its Form 8-K filed January 27, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Shareholders approved the adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of ”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 13,904,685 for, 246,173 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,286,793 | 0 | 0 | 0 | For |
| BlackRock | 2,786,683 | 0 | 0 | 0 | For |
| Fidelity | 1,408,438 | 0 | 0 | 0 | For |
| Charles Schwab | 416,223 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 360,685 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,300 | 124,500 | 0 | 0 | Against |
| Equitable | 119,670 | 0 | 0 | 0 | For |
| Global X | 81,445 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 66,979 | 0 | 0 | Against |
| Pacific Life | 66,327 | 0 | 0 | 0 | For |
| TIAA | 62,808 | 0 | 0 | 0 | For |
| State Street | 0 | 47,331 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 44,600 | 0 | 0 | 0 | For |
| ProShares | 42,841 | 0 | 0 | 0 | For |
| Northern Trust | 39,931 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| John Hancock | 32,559 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,518 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 31,143 | 0 | 0 | 0 | For |
| DWS | 19,932 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| Victory Capital | 7,443 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 5,100 | 0 | 0 | Against |
| Jackson National | 4,400 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,062 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Meeting held June 26, 2025.
92% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to the Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan to increase the number of common shares available thereunder by 19,500,000.
The 28 asset managers below reported 6,695,021 for, 551,234 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 128,800 | 0 | 0 | Against |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 96,314 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 94,050 | 0 | 0 | Against |
| Equitable | 38,382 | 46,580 | 0 | 0 | Mixed |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 0 | 38,835 | 0 | 0 | Against |
| ProShares | 0 | 32,821 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 23,397 | 0 | 0 | Against |
| Victory Capital | 0 | 22,856 | 0 | 0 | Against |
| DWS | 0 | 22,379 | 0 | 0 | Against |
| Calvert | 0 | 10,656 | 0 | 0 | Against |
| State Street | 0 | 8,516 | 0 | 0 | Against |
| Goldman Sachs | 0 | 6,462 | 0 | 0 | Against |
| John Hancock | 0 | 6,217 | 0 | 0 | Against |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 5,100 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 3,700 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 2,263 | 0 | 0 | Against |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Meeting held June 26, 2025.
Combines 9 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“3. The compensation paid to the Company's named executive officers, as set forth in the Proxy Statement, by the following votes”): 96,071,162 for, 3,804,451 against — passed, per its Form 8-K filed July 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers, as set forth in the Proxy Statement, by the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 124,500 | 4,300 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Fund voting reports, all 28 managers: 7,241,955 for, 4,300 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RAFFLES ASSOCIATES LP | 5,642,088 | 0 | 0 | 0 | For |
| COMERICA BANK | 4,000,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,375,807 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 2,511,374 | 0 | 0 | 0 | For |
| BlackRock | 1,920,745 | 0 | 0 | 0 | For |
| State Street | 1,227,866 | 0 | 0 | 0 | For |
| Northern Trust | 832,204 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 497,938 | 0 | 0 | 0 | For |
| Phoenix Financial Ltd. | 0 | 479,350 | 0 | 0 | Against |
| RBC Capital Markets, LLC | 437,028 | 0 | 0 | 0 | For |
| Two Sigma | 383,277 | 0 | 0 | 0 | For |
| Vanguard | 263,400 | 0 | 0 | 0 | For |
| Prescott General Partners LLC | 262,000 | 0 | 0 | 0 | For |
| Fidelity | 195,045 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 135,059 | 0 | 0 | 0 | For |
| JPMorgan | 81,248 | 0 | 0 | 0 | For |
| Rhumbline | 58,723 | 0 | 0 | 0 | For |
| Invesco | 56,582 | 0 | 0 | 0 | For |
| Citadel | 54,516 | 0 | 0 | 0 | For |
| AllianceBernstein | 46,580 | 0 | 0 | 0 | For |
| CIBC WORLD MARKET INC. | 46,050 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| TRUST CO OF TOLEDO NA /OH/ | 35,394 | 0 | 0 | 0 | For |
| SCOTIA CAPITAL INC. | 26,750 | 0 | 0 | 0 | For |
Institutional-manager reports, all 98 managers: 22,896,061 for, 520,639 against. Showing the 25 largest; see all in the interactive database.
Meeting held June 26, 2025.
Combines 2 wordings of this item as funds reported it.
99.4% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.
LINEAGE CELL THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 by the following votes”): 158,952,692 for, 912,282 against — passed, per its Form 8-K filed July 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Shareholders ratified the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 by the following votes:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,246,255 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,905,515 | 0 | 0 | 0 | For |
| Vanguard | 2,395,702 | 0 | 0 | 0 | For |
| Charles Schwab | 503,193 | 0 | 0 | 0 | For |
| BlackRock | 342,508 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 291,019 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,800 | 0 | 0 | 0 | For |
| Global X | 105,098 | 0 | 0 | 0 | For |
| Northern Trust | 96,314 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 94,050 | 0 | 0 | 0 | For |
| Equitable | 84,962 | 0 | 0 | 0 | For |
| Pacific Life | 66,912 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,529 | 0 | 0 | 0 | For |
| Voya | 38,835 | 0 | 0 | 0 | For |
| ProShares | 32,821 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 23,397 | 0 | 0 | 0 | For |
| Victory Capital | 22,856 | 0 | 0 | 0 | For |
| DWS | 22,379 | 0 | 0 | 0 | For |
| Calvert | 10,656 | 0 | 0 | 0 | For |
| State Street | 8,516 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,462 | 0 | 0 | 0 | For |
| John Hancock | 6,217 | 0 | 0 | 0 | For |
| TIAA | 5,156 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 5,100 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,700 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,263 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 228,356,290 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 1.27% |
| 2 | Vanguard | 1.05% |
| 3 | Charles Schwab | 0.22% |
| 4 | BlackRock | 0.15% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.13% |
| 6 | Lincoln Financial | 0.06% |
| 7 | Global X | 0.05% |
| 8 | Northern Trust | 0.04% |
| 9 | AIG/SunAmerica | 0.04% |
| 10 | Equitable | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RAFFLES ASSOCIATES LP | 2.47% |
| 2 | COMERICA BANK | 1.75% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.48% |
| 4 | DAFNA Capital Management LLC | 1.10% |
| 5 | BlackRock | 0.84% |
| 6 | State Street | 0.54% |
| 7 | Northern Trust | 0.36% |
| 8 | Charles Schwab | 0.22% |
| 9 | MELLON INVESTMENTS Corp | 0.22% |
| 10 | Phoenix Financial Ltd. | 0.21% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BROADWOOD PARTNERS, L.P. | 25.16% | 13D |
| Neal C. Bradsher | 21.84% | DEF14A |
| BlackRock | 5.02% | 13F |
| Chernett Jorey | 5.01% | 13G |
| Vanguard Group | 3.91% | 13F |
| Brian M. Culley | 3.00% | DEF14A |
| Geode Capital | 1.96% | 13F |
| State Street | 1.16% | 13F |
| Renaissance Technologies | 1.00% | 13F |
| George A. Samuel III | 0.78% | DEF14A |
Percentages above are of 228,356,290 shares outstanding, as reported by LINEAGE CELL THERAPEUTICS INC. on its Form 10-Q dated May 7, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LINEAGE CELL THERAPEUTICS INC.’s 10-Q dated May 7, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At LINEAGE CELL THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held January 27, 2025 and June 26, 2025), 120 asset managers reported how they voted in their SEC Form N-PX filings, covering 933 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 26, 2025 — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. — LINEAGE CELL THERAPEUTICS INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: LINEAGE CELL THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 2, 2025.
LINEAGE CELL THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.